Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
This article was originally published in The Gray Sheet
Executive Summary
Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer